S
Sera Economics
← US Companies

BIOGEN INC.

BIIB · Nasdaq · CIK 0000875045

SIC 2836

Biological Products, (No Diagnostic Substances)

Category

Chemicals

Entity

operating

Incorp.

DE

Fiscal Y/E

1231

Source: SEC EDGAR · All filings on SEC →

Investment Indicators

ROE

8.74%

ROA

4.39%

D/E Ratio

0.76

Current Ratio

2.68

Gross Margin

117.68%

Operating Margin

28.72%

Net Margin

13.07%

Book Value/Share

$100.81

Financial Statements

In USD millions (per-share figures shown directly) · Financials as of: 2026-02-06

Income Statement

FY20252024202320222021
Revenue9,8919,6769,83610,17310,982
Operating Income2,841
Net Income1,2931,6321,1613,0471,556
EPS (Basic)8.8311.218.0220.9610.44
EPS (Diluted)8.7911.187.9720.8710.40

Balance Sheet

FY20252024202320222021
Total Assets29,44028,04926,84524,55423,877
Current Assets8,9747,4576,8599,7917,857
Total Liabilities11,18311,33312,04511,16612,918
Current Liabilities3,3495,5293,4343,2734,298
Long-term Debt6,2876,2966,9386,2816,274
Total Equity14,79913,39810,896

Cash Flow

FY20252024202320222021
Operating CF2,2052,8761,5471,3843,640
Investing CF-1,371-799-4,1011,577-564
Financing CF-302-684149-1,747-2,086
CapEx154154277240258

📄 SEC Filings

Other filings (78)
SCHEDULE 13D/A

SCHEDULE 13D/A

xslSCHEDULE_13D_X02/primary_doc.xml

2026-05-14

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2026-05-14

Open →

SC TO-T/A

SC TO-T/A

AMENDMENT NO. 2

2026-05-12

Open →

SC TO-T/A

SC TO-T/A

AMENDMENT NO. 1

2026-05-06

Open →

SCHEDULE 13G/A

SCHEDULE 13G/A

xslSCHEDULE_13G_X02/primary_doc.xml

2026-05-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-05-05

Open →

SCHEDULE 13G

SCHEDULE 13G

xslSCHEDULE_13G_X02/primary_doc.xml

2026-04-29

Open →

ARS

ARS

ARS

2026-04-28

Open →

DEFA14A

DEFA14A

DEFA14A

2026-04-28

Open →

SC TO-T

SC TO-T

SC TO-T

2026-04-14

Open →

SC TO-C

SC TO-C

SCHEDULE TO

2026-04-07

Open →

3

3

xslF345X06/form3.xml

2026-04-06

Open →

SCHEDULE 13D

SCHEDULE 13D

xslSCHEDULE_13D_X02/primary_doc.xml

2026-04-06

Open →

SC TO-C

SC TO-C

SCHEDULE TO

2026-04-03

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-04-03

Open →

SC TO-C

SC TO-C

SC TO-C

2026-03-31

Open →

SC TO-C

SC TO-C

SCHEDULE TO

2026-03-31

Open →

SCHEDULE 13G/A

SCHEDULE 13G/A

xslSCHEDULE_13G_X02/primary_doc.xml

2026-03-26

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-17

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-17

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-17

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-17

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-17

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-17

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-17

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-17

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-17

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-17

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-10

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-10

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-10

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-10

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-10

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-10

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-10

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-10

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-10

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-10

Open →

144

144

xsl144X01/primary_doc.xml

2026-02-09

Open →

SCHEDULE 13G

SCHEDULE 13G

xslSCHEDULE_13G_X01/primary_doc.xml

2026-02-05

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-03

Open →

144

144

xsl144X01/primary_doc.xml

2026-02-02

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-03

Open →

SCHEDULE 13G/A

SCHEDULE 13G/A

xslSCHEDULE_13G_X01/primary_doc.xml

2025-11-13

Open →

SCHEDULE 13G

SCHEDULE 13G

xslSCHEDULE_13G_X01/primary_doc.xml

2025-11-10

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-11-04

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-10-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-09-02

Open →

144

144

xsl144X01/primary_doc.xml

2025-09-02

Open →

SCHEDULE 13D/A

SCHEDULE 13D/A

xslSCHEDULE_13D_X01/primary_doc.xml

2025-07-30

Open →

SCHEDULE 13D/A

SCHEDULE 13D/A

xslSCHEDULE_13D_X01/primary_doc.xml

2025-07-21

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-07-16

Open →

144

144

xsl144X01/primary_doc.xml

2025-07-08

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-06-18

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-06-18

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-06-18

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-06-18

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-06-18

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-06-18

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-06-18

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-06-18

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-06-18

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-06-18

Open →

DEFA14A

DEFA14A

DEFA14A

2025-06-02

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-05-20

Open →

144

144

xsl144X01/primary_doc.xml

2025-05-19

Open →

424B2

424B2

424B2

2025-05-08

Open →

FWP

FWP

FWP

2025-05-06

Open →

424B2

424B2

424B2

2025-05-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-05-05

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-05-05

Open →

S-3ASR

S-3ASR

S-3ASR

2025-05-01

Open →

ARS

ARS

ARS

2025-04-28

Open →

DEFA14A

DEFA14A

DEFA14A

2025-04-28

Open →

SCHEDULE 13G/A

SCHEDULE 13G/A

xslSCHEDULE_13G_X01/primary_doc.xml

2025-04-17

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-04-03

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-03-10

Open →

3

3

PRIMARY DOCUMENT

2025-03-10

Open →

BIOGEN INC. (BIIB) — Biological Products, (No Diagnostic Substances) | Sera Economics